Patents Assigned to Roche Diagnostics GmbH
  • Patent number: 6544748
    Abstract: The invention relates to human cells which are capable, on the basis of an activation of the endogenous human EPO gene, of producing EPO in a sufficient amount and purity to make possible a cost-effective production of human EPO as a pharmaceutical preparation. The invention furthermore relates to a method for the preparation of such human EPO-producing cells, DNA constructs for the activation of the endogenous EPO in human cells, and a method for the large technical production of EPO in human cells.
    Type: Grant
    Filed: November 2, 2001
    Date of Patent: April 8, 2003
    Assignee: Roche Diagnostics GmbH
    Inventors: Anne Stern, Michael Brandt, Konrad Honold, Johannes Auer, Hans Koll
  • Patent number: 6545143
    Abstract: Preparations of particles having a glass surface, wherein more than 75% by weight of these particles have a particle size between 0.5 &mgr;m and 15 &mgr;m and a glass surface which contains between 2 and 6 mole % zinc oxide, have proven to be particularly advantageous in processes for the purification of nucleic acids. This in particular results in an increased nucleic acid yield.
    Type: Grant
    Filed: January 9, 2002
    Date of Patent: April 8, 2003
    Assignee: Roche Diagnostics, GmbH
    Inventors: Herbert Harttig, Michael Riedling, Martin Mennig, Helmut Schmidt
  • Patent number: 6544796
    Abstract: A system for producing multiple diagnostic test elements has a support (1) with an analytical region (3) to which diagnostic test spots (8) are applied, one or several stop edges (11-13) for each direction in space for positioning the support, a first holding unit (10I) into which the support is inserted and positioned by means of the one or more stop edges, a first printing head (20I) arranged above the holding unit (10) for applying drops of a first liquid to the analytical region of the support (1), a first positioning unit which laterally displaces and positions the first holding unit, a second holding unit (10II) into which the support is inserted and positioned by means of the one or more stop edges, a second printing head (20II) arranged above the second holding unit for applying drops of a second liquid to the analytical region of the support (1), a second positioning unit which laterally displaces and positions the second holding unit, a transport unit (41) and a control unit.
    Type: Grant
    Filed: March 31, 2000
    Date of Patent: April 8, 2003
    Assignee: Roche Diagnostics GmbH
    Inventors: Udo Eichenlaub, Martin Masch
  • Publication number: 20030059468
    Abstract: The present invention concerns processes for the production of dry, partially amorphous products containing biologically active and in particular therapeutically active material which are macroscopically homogeneous substance mixtures, the substance mixtures being selected from at least one substance of each of the groups
    Type: Application
    Filed: May 10, 2002
    Publication date: March 27, 2003
    Applicant: Roche Diagnostics GmbH
    Inventors: Markus Mattern, Gerhard Winter
  • Patent number: 6537496
    Abstract: A flat-shaped functional overlay for at least one region of a flat-shaped flexible object which does not form a fold when the sandwich composed of the flexible object and overlay is bent towards the side on which the overlay is located is described. The overlay is composed of one or several flat-shaped overlays which are attached to the flexible object in such a way that a part of their surface can move freely relative to the surface of the object covered by this part in the direction of curvature produced when the object is bent. In addition diagnostic test strips are described which have such an overlay.
    Type: Grant
    Filed: October 22, 1999
    Date of Patent: March 25, 2003
    Assignee: Roche Diagnostics GmbH
    Inventors: Wolfgang-Reinhold Knappe, Helmut Leininger, Ralf Steinbrueck, Franz Wittmann
  • Patent number: 6534017
    Abstract: The invention concerns a magazine for storing test elements (1) with one or several test zones (3) which are attached adjacent to one another on a rectangular support, wherein the magazine has at least one pair of guide grooves (18a, b) located opposite to one another into which the test elements are inserted in such a way that they lie directly adjacent to one another and the edges of adjacent supports abut one another. A further subject matter of the invention is a system which comprises a slide (14, 31) in addition to the magazine according to the invention which is used to push a layer of test elements along the guide grooves towards the opposite end of the layer to remove test elements from the magazine.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: March 18, 2003
    Assignee: Roche Diagnostics GmbH
    Inventors: Gunter Bottwein, Reinhard Bär, Hans List, Friedrich Heid
  • Patent number: 6531572
    Abstract: Metal chelate-labelled peptide which has a maximum length of 50 amino acids and is coupled to at least one luminescent metal chelate at the amino terminus or/and at amino side groups, wherein the at least one luminescent metal chelate is present on the peptide at a predetermined position on the peptide.
    Type: Grant
    Filed: January 24, 1997
    Date of Patent: March 11, 2003
    Assignee: Roche Diagnostics GmbH
    Inventors: Christoph Seidel, Ursula-Henrike Wienhues, Eva Höss
  • Patent number: 6531702
    Abstract: Sample carrier for IR spectroscopy which has a sample application zone as well as at least one groove-shaped channel into which liquid is drawn from the sample application zone as a result of capillary forces. A method for IR spectroscopy using a sample carrier according to the invention and a system for IR spectroscopy using the sample carrier according to the invention.
    Type: Grant
    Filed: May 25, 2000
    Date of Patent: March 11, 2003
    Assignee: Roche Diagnostics GmbH
    Inventors: Reinhold Mischler, Dirk Boecker
  • Patent number: 6528619
    Abstract: The present invention provides peptides as inhibitors of the binding of urokinase to the urokinase receptor. The peptides have the general structural formula (I): X1-[X2]n-X3-X4-K-Y-F-X5-X6-I-X7-W-[X8]m  (I) in which X1, X2, X3, X4, X5, X6, X7 and X8 each denote an aminocarboxylic acid, n and m are each independently 0 or 1, K denotes an aminocarboxylic acid with a lysine side chain, Y denotes an aminocarboxylic acid with a tyrosine side chain, F denotes an aminocarboxylic acid with a phenyl-alanine side chain, I denotes an aminocarboxylic acid with an isoleucine side chain, W denotes an aminocarboxylic acid with a tryptophan side chain, and the monomeric building blocks are linked by —CONR1— or —NR1CO— bonds where R1 in each case independently denotes hydrogen, methyl or ethyl, and pharmaceutically compatible salts and derivatives thereof.
    Type: Grant
    Filed: January 10, 2000
    Date of Patent: March 4, 2003
    Assignee: Roche Diagnostics GmbH
    Inventors: Markus Bürgle, Heinrich Graeff, Horst Kessler, Viktor Magdolen, Bernhard König, Marcus Koppitz, Christoph Riemer, Manfred Schmitt, Ulrich Weidle
  • Patent number: 6524834
    Abstract: The present application relates to a diisopropyl-fluorophosphatase from Loligo vulgaris, and to the amino acid and nucleic acid sequences encoding the enzyme. Also provided are vectors which contain the DNA sequence according to the invention, and to cells transformed with the base sequence according to the invention. Finally, the present application also provides a method for the production of the diisopropyl-fluorophosphatase and various types of use and areas of employment of the diisopropyl-fluorophosphatase, in particular the decontamination of contaminated habitats, the production of medicinal products for treating or detoxifying humans and animals, the impregnation of clothing and the use in analyses.
    Type: Grant
    Filed: November 27, 2000
    Date of Patent: February 25, 2003
    Assignee: Roche Diagnostics GmbH
    Inventors: Heinz Ruterjans, Stefan Dierl
  • Publication number: 20030035967
    Abstract: The invention concerns a process for coating a metallic or semimetallic surface in which coating molecules containing reactive groups are bound covalently to the surface by irradiation with light and it also concerns a structured coated surface.
    Type: Application
    Filed: June 17, 2002
    Publication date: February 20, 2003
    Applicant: Roche Diagnostics GMBH
    Inventor: Franz Effenberger
  • Patent number: 6518058
    Abstract: The present invention provides a method for synthesis polypeptides in a cell-free system by which products of synthesis are branched in a low molecular weight fraction and a fraction which contains high molecular weight components with the target polypeptide, the main part of the low molecular weight fraction is removed via at least one part of the second porous barrier, the ratio of the volume of the fractions of feed solution and expendable components to the volume of the fraction containing the target polypeptide is chosen, modes of supply of the feed solution and expendable components of the fraction are realized.
    Type: Grant
    Filed: April 23, 2001
    Date of Patent: February 11, 2003
    Assignee: Roche Diagnostics GmbH
    Inventors: Sergey Vladimirovich Biryukov, Peter Nikolayevich Simonenko, Vladimir Anatolievich Shirokov, Sergey Gennadievich Mayorov, Alexander Sergeyevich Spirin
  • Patent number: 6506575
    Abstract: The invention concerns an analytical element for determining the amount of an analyte in a liquid containing a sample application zone (1) and a detection zone (2) which are in liquid-transferring contact, the latter containing at least one enzyme and an indicator substance, the enzyme catalysing a reaction in which the analyte or a substance derived from the analyte participates and the indicator substance forming a signal when the analyte is present which signal correlates with the amount of analyte, and containing a liquid-permeable interference-reducing layer (3) in direct contact with the detection zone (2) arranged such that liquid does not reach the detection zone until it has passed through the interference-reducing layer, the interference-reducing layer containing at least one enzyme which participates in a reaction of the analyte to be determined or of a substance derived from the analyte, wherein the analyte or the substance derived from the analyte is converted enzymatically in the interference-re
    Type: Grant
    Filed: September 22, 2000
    Date of Patent: January 14, 2003
    Assignee: Roche Diagnostics GmbH
    Inventors: Wolfgang Reinhold Knappe, Rudolf Pachl, Otto Gaa
  • Patent number: 6503714
    Abstract: The invention concerns a method of detecting a substance to be analyzed in a sample by contacting the sample with a probe which contains nucleobases and two or more non-nucleosidic marker-promoting groups in conditions in which the substance to be analyzed binds indirectly or directly to the probe. The method enables the binding product to be detected. The probe is preferably branched.
    Type: Grant
    Filed: November 16, 2000
    Date of Patent: January 7, 2003
    Assignee: Roche Diagnostics GmbH
    Inventors: Kurt Weindel, Christoph Seidel, Gerhard Lassonczyk
  • Patent number: 6503706
    Abstract: The invention addresses DNA-protein-complexes, proteins, DNA sequences and antibodies that are suitable for the detection of cells with an unlimited proliferation and tumor-formation potential. The invention further addresses methods for obtaining such proteins or DNA sequences and methods for identifying animal and human cells with with an unlimited proliferation and tumor-formation potential using such proteins, DNA sequences or antibodies.
    Type: Grant
    Filed: January 16, 1996
    Date of Patent: January 7, 2003
    Assignee: Roche Diagnostics GmbH
    Inventors: Hinrich Johann Abken, Winfried Albert, Herbert Jungfer
  • Patent number: 6503720
    Abstract: Methods are provided for quantifying the concentration of a nucleic acid in a nucleic acid sample. The methods include contacting the nucleic acid sample with an amplifying agent, amplifying at least one predetermined locus of the nucleic acid by subjecting the sample to a number of amplification, generating an amplification curve or array, calculating the first, second or n th order derivative of the amplification curve or array, determining a maximum, minimum, or zero value of the derivative, and using the maximum, minimum, or zero value to calculate the initial concentration of the nucleic acid in the nucleic acid sample.
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: January 7, 2003
    Assignees: Roche Diagnostics GmbH, University of Utah Research Foundation
    Inventors: Carl T. Wittwer, Martin Gutekunst, Sabine Lohmann
  • Patent number: 6497845
    Abstract: A storage container for holding analytical devices, the storage container being made of a rigid material and containing separate chambers in each of which at most one analytical device can be accommodated, wherein the chambers are in a regular geometric arrangement in relation to one another and each of the chambers has at least two opposite openings each sealed by a foil, wherein at least one of the chambers comprises a means for fixing the position of an analytical device in the chamber. In addition the invention concerns a system for storing analytical devices containing a storage container according to the invention and two or more analytical devices.
    Type: Grant
    Filed: April 23, 1999
    Date of Patent: December 24, 2002
    Assignee: Roche Diagnostics GmbH
    Inventor: Klaus-Dieter Sacherer
  • Patent number: 6498241
    Abstract: 2′-Deoxyisoguanosine, isosteric analogues and isoguanosine derivatives of formulae I-V, processes for their production via compounds of the general formulae a or b and reaction with aroyl isocyanates or from compounds of the general formulae VI-IX by photochemical irradiation. A further production process is the conversion of deoxyguanosines or guanosines by means of persilylation, reaction with ammonia and deamination in the 2 position. The compounds are suitable as pharmaceutical agents with antiviral efficacy.
    Type: Grant
    Filed: November 13, 2000
    Date of Patent: December 24, 2002
    Assignee: Roche Diagnostics GmbH
    Inventors: Frank Seela, Zigmunt Kasimierczuk, Klaus Mühlegger, Herbert Von Der Eltz
  • Publication number: 20020185161
    Abstract: The invention concerns a device for cleaning pipette needles or stirrers, the device comprising a trough which holds cleaning fluid and whose lower region has a fluid duct for filling and/or emptying purposes and whose upper region has at least one feed pipe which leads into at least one nozzle directed into the trough interior. Advantageously, the device has a cylindrical trough and in insert with nozzles which is screwed into the trough. The invention further concerns a method of cleaning pipette needles or stirrers, the material to be washed being introduced into the trough interior and sprayed with a washing fluid. The device can also be sued to flush the interior of a pipette needle.
    Type: Application
    Filed: June 28, 2002
    Publication date: December 12, 2002
    Applicant: Roche Diagnostics GmbH
    Inventors: Otto Furst, Thomas Jack, Peter Weber, Paul Jansen
  • Patent number: 6489129
    Abstract: The invention concerns a method for the determination of antigen-specific antibodies of the immunoglobulin M class in the presence of immunoglobulins of the G class and/or rheumatoid factors in body fluids by incubation with at least two different receptors R1 and R2 and optionally additional receptors wherein an essential component of R2 is a binding partner in a polymeric form and interference by IgG antibodies of the same antigen specificity is reduced by binding partners in a monomeric form; a reagent for determining an antigen-specific antibody of the immunoglobulin M class, as well as the use of binding partners in a monomeric form to reduce interference by IgG antibodies in the determination of antigen-specific IgM antibodies.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: December 3, 2002
    Assignee: Roche Diagnostics GmbH
    Inventors: Elke Faatz, Urban Schmitt, Beatus Ofenloch-Hahnle